ProtonDx's core technology builds on several years of innovative research in diagnostics and sample extractions, fuelled by unique collaborations between engineering, medicine and molecular biology.
ProtonDx Ltd is founded at Imperial College, London by Dr. Jesus Rodriguez Manzano, Dr. Pantelis Georgiou, and Dr. Nicolas Moser (from left to right), based on their Lab-on-Chip diagnostic technology.
Development of Dragonfly
Product Development ramps up for Dragonfly, a point-of-care, in vitro diagnostic device.
ProtonDx goes Olympic
The Dragonﬂy Respiratory Test Panel is deployed by Team GB at the 2022 Winter Olympic Games in Beijing, China.
Dragonfly used in Commonwealth Games
Dragonfly used by Team Scotland at the Commonwealth Games for quick and reliable testing.
Bob Enck joins the team as Chairman & President.
Porcine Grant Secured
The company receives a £365,000 grant to develop rapid point-of-care tests for porcine lung diseases.
Dragonfly Receives CE-IVD Mark
Dragonfly, a product that enables rapid and accurate identification of 5 different respiratory viruses, including SARS-CoV-2, Flu A, Flu B, RSV, and Human rhinovirus, receives CE-IVD Mark.
ProtonDx launches SmartLid, a Viral RNA/DNA Extraction Kit for Research Use Only.